Seroprevalence, correlates and kinetics of SARS-CoV-2 Nucleocapsid IgG antibody in healthcare workers at a tertiary hospital: A prevaccine census study

Daniel Maina, Geoffrey Omuse, George Ong’ete, Patrick Mugaine, Shahin Sayed, Zahir Moloo, Reena Shah, Anthony Etyang, Rodney Adam
doi: https://doi.org/10.1101/2022.04.13.22273817

Article Information

doi 
https://doi.org/10.1101/2022.04.13.22273817
History 
  • April 16, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Daniel Maina1,*,
  2. Geoffrey Omuse1,
  3. George Ong’ete2,
  4. Patrick Mugaine1,
  5. Shahin Sayed1,
  6. Zahir Moloo1,3,
  7. Reena Shah4,
  8. Anthony Etyang5 and
  9. Rodney Adam1,4
  1. 1Department of Pathology & Laboratory Medicine, Aga Khan University Hospital, Nairobi
  2. 2Occupational Safety & Health, Aga Khan University Hospital, Nairobi
  3. 3Aga khan Health Services
  4. 4Department of Internal Medicine, Aga Khan University Hospital Nairobi
  5. 5KEMRI–Wellcome Trust Research Programme, Kilifi, Kenya
  1. ↵*Corresponding author Email: daniel.maina{at}aku.edu
Back to top
Posted April 16, 2022.
Download PDF
Data/Code
Email
Seroprevalence, correlates and kinetics of SARS-CoV-2 Nucleocapsid IgG antibody in healthcare workers at a tertiary hospital: A prevaccine census study
Daniel Maina, Geoffrey Omuse, George Ong’ete, Patrick Mugaine, Shahin Sayed, Zahir Moloo, Reena Shah, Anthony Etyang, Rodney Adam
medRxiv 2022.04.13.22273817; doi: https://doi.org/10.1101/2022.04.13.22273817
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area